Cari, L.; Naghavi Alhosseini, M.; Mencacci, A.; Migliorati, G.; Nocentini, G.
Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World. Vaccines 2023, 11, 879.
https://doi.org/10.3390/vaccines11040879
AMA Style
Cari L, Naghavi Alhosseini M, Mencacci A, Migliorati G, Nocentini G.
Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World. Vaccines. 2023; 11(4):879.
https://doi.org/10.3390/vaccines11040879
Chicago/Turabian Style
Cari, Luigi, Mahdieh Naghavi Alhosseini, Antonella Mencacci, Graziella Migliorati, and Giuseppe Nocentini.
2023. "Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World" Vaccines 11, no. 4: 879.
https://doi.org/10.3390/vaccines11040879
APA Style
Cari, L., Naghavi Alhosseini, M., Mencacci, A., Migliorati, G., & Nocentini, G.
(2023). Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World. Vaccines, 11(4), 879.
https://doi.org/10.3390/vaccines11040879